Article

The colorectal malignant polyp: Scoping a dilemma

“Regina Elena” National Cancer Institute, Rome, Italy
Digestive and Liver Disease (Impact Factor: 2.89). 02/2007; 39(1):92-100. DOI: 10.1016/j.dld.2006.06.039
Source: PubMed

ABSTRACT Colorectal adenomas containing invasive carcinoma represent the majority of early colorectal cancers. The malignant polyp carries a significant risk of lympho-haematic metastasis and mortality due to the penetration of cancerous cells into the submucosal layer. The therapeutic dilemma is whether to perform endoscopic or surgical resection. A thorough assessment of the endoscopic, histological and clinical variables is needed to unravel the best treatment for each patient. In particular, a unique staging of such lesions, based on certain histopathological features, has been deeply implicated in the therapeutic choice. Aim of this article is to review the main endoscopic, histological and clinical features of the malignant polyp in order to propose a systematic management of this lesion.

Download full-text

Full-text

Available from: Francesco Paolo Rossini, Aug 26, 2015
0 Followers
 · 
243 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Colorectal cancer is the second most common cause of cancer-related death in the Western world. Its development is typically through colorectal adenomas. Colorectal cancer prevalence may be reduced substantially by primary prevention including colonoscopy and polypectomy. Secondary prevention applies to populations that have been diagnosed with colorectal adenomas, and its goal is to prevent the development of additional adenomas. It is accomplished mainly by endoscopic surveillance with polypectomy. Additional measures include chemoprevention, used in selected patients only, and modification of risk factors such as smoking, high body mass index, and poor nutrition. This article reviews the current professional guidelines for endoscopic surveillance and adherence by physicians and patients. Measures to increase surveillance efficacy include standardization of colonoscopy among endoscopists and enhanced endoscopy techniques. This article also reviews evidence for the impact of lifestyle modification. It appears that the endoscopic surveillance protocol is often personalized because of the lack of standardization of baseline colonoscopy, suboptimal adherence to the guidelines, and a deficiency in the guidelines with regard to proper risk stratification.
    Current Colorectal Cancer Reports 01/2010; 6(1):16-23. DOI:10.1007/s11888-009-0037-2
  • Source
    Gastroenterology 01/1996; 109(6):2034-5. DOI:10.1016/0016-5085(95)90775-0 · 13.93 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Invasive colorectal carcinomas (CRCs) with invasion confined to the lamina propria (LP) [intramucosal carcinoma (IMC)] lack access to lymphatics and therefore have no potential for metastases and local intervention (usually polypectomy) should be adequate treatment. For this reason, they are classified as "Tis" in the TNM system. It is believed that carcinomas invading the submucosa with unfavorable histology (tumors at/near the margin, and/or vascular invasion, and/or poor differentiation) require additional intervention after polypectomy, whereas those with favorable histology can be safely treated endoscopically. However, there are few data on poorly differentiated (PD) carcinomas showing invasion confined to the LP. Polypectomy is theoretically curative but in practice this has not been well demonstrated. Thus, the clinicopathologic features of 15 cases of PD CRCs with invasion limited to the LP on initial biopsies were studied to determine the best course of management for this rare subset of carcinomas. A computer search and histologic review of cases seen at Johns Hopkins Hospital was performed. Fifteen cases of PD CRC with invasion limited to the LP were identified. The clinicopathologic features of these tumors were reviewed. All 15 cases showed PD IMC with single cells infiltrating only the LP. Patients were 38 to 79 years (median, 62) of age with a male predominance (M:F=4:1). Three cases had signet ring cell differentiation, 1 had focal small cell features, and another had focal squamous differentiation. Fourteen of the cases were associated with background adenomas or adenomalike lesions including: 7 involving tubulovillous or villous adenomas, 6 involving tubular adenomas, 1 involving dysplasia associated with chronic inflammatory bowel disease. Nine of the lesions had surrounding high-grade dysplasia. One case showed no background dysplasia or adenoma. One patient was lost to follow-up and the remaining 14 were followed for 1 to 96 months (mean, 21.3 mo; median, 13 mo). Seven patients had no residual disease on follow-up colonoscopy, and no resection was performed. The remaining 7 patients were treated with partial colectomy (6) or low anterior resection (1), and of these, 5 had no infiltrating carcinoma and negative lymph nodes. One patient had a separate large colorectal (T3) carcinoma with 8/10 positive regional lymph nodes; the IMC seen on biopsy was presumably a metastasis as it was unassociated with an in situ component. Finally, the resected rectum from which an IMC had been previously detected had no residual invasive carcinoma, but the anal skin was involved by Paget disease. Thus, of the 15 cases of PD CRCs limited to the LP, 1 was a metastasis from a separate CRC and another had associated Paget disease of the anal skin. As such, even in the setting of PD carcinomas, no metastatic disease was seen arising from any of the cases that were confirmed as early primary lesions. These preliminary findings suggest that patients with isolated intramucosal PD CRCs may be managed endoscopically.
    American Journal of Surgical Pathology 01/2008; 31(12):1882-6. DOI:10.1097/PAS.0b013e318057fac2 · 4.59 Impact Factor
Show more